Nuclear ERK: mechanism of translocation, substrates, and role in cancer
G Maik-Rachline, A Hacohen-Lev-Ran… - International journal of …, 2019 - mdpi.com
The extracellular signal-regulated kinases 1/2 (ERK) are central signaling components that
regulate stimulated cellular processes such as proliferation and differentiation. When …
regulate stimulated cellular processes such as proliferation and differentiation. When …
NF-κB pathways in the development and progression of colorectal cancer
Nuclear factor-κB (NF-κB) has been widely implicated in the development and progression
of cancer. In colorectal cancer (CRC), NF-κB has a key role in cancer-related processes …
of cancer. In colorectal cancer (CRC), NF-κB has a key role in cancer-related processes …
Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
M Wan, Y Wang, Z Zeng, B Deng, B Zhu… - Bioscience …, 2020 - portlandpress.com
Colorectal cancer (CRC) is the third most common malignancy and one of the leading
causes of cancer-related death among men worldwide. CRC is a multifactor digestive …
causes of cancer-related death among men worldwide. CRC is a multifactor digestive …
Impact of ERK5 on the Hallmarks of Cancer
Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein
kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic …
kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic …
Oncogenic signaling of MEK5-ERK5
VT Hoang, TJ Yan, JE Cavanaugh, PT Flaherty… - Cancer letters, 2017 - Elsevier
Mitogen-activated protein kinases (MAPKs) regulate diverse cellular processes including
proliferation, cell survival, differentiation, and apoptosis. While conventional MAPK …
proliferation, cell survival, differentiation, and apoptosis. While conventional MAPK …
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target
AES Simoes, CMP Rodrigues, PM Borralho - Drug discovery today, 2016 - Elsevier
Highlights•The present review highlights the emerging clinical relevance of MEK5/ERK5
signalling as a therapeutic target and prognostic factor in several top-leading diagnosed …
signalling as a therapeutic target and prognostic factor in several top-leading diagnosed …
Induction of apoptosis in human leukemia cells through an intrinsic pathway by cathachunine, a unique alkaloid isolated from Catharanthus roseus
XD Wang, CY Li, MM Jiang, D Li, P Wen, X Song… - Phytomedicine, 2016 - Elsevier
Abstract Background Catharanthus roseus (L.) G. Don consists of a range of dimeric indole
alkaloids with significant antitumor activities. These alkaloids have been found to possess …
alkaloids with significant antitumor activities. These alkaloids have been found to possess …
Clinical significance and regulation of ERK5 expression and function in cancer
M Monti, J Celli, F Missale, F Cersosimo, M Russo… - Cancers, 2022 - mdpi.com
Simple Summary Alterations of the MEK5/ERK5 signaling pathway have been described in
several tumors, and emerging data are trying to explain the complexity of ERK5-related …
several tumors, and emerging data are trying to explain the complexity of ERK5-related …
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
N Diéguez-Martínez, S Espinosa-Gil, G Yoldi… - Cellular and Molecular …, 2022 - Springer
Endometrial cancer (EC) is the most common type of gynecologic cancer in women of
developed countries. Despite surgery combined with chemo-/radiotherapy regimens, overall …
developed countries. Despite surgery combined with chemo-/radiotherapy regimens, overall …
ERK5 signalling and resistance to ERK1/2 pathway therapeutics: The path less travelled?
SJ Cook, PA Lochhead - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
The RAS-regulated RAF-MEK1/2-ERK1/2 signalling pathway is frequently de-regulated in
human cancer. Melanoma in particular exhibits a high incidence of activating BRAFV600E/K …
human cancer. Melanoma in particular exhibits a high incidence of activating BRAFV600E/K …